SPH3127

· Shanghai Pharmaceuticals Holding Co., Ltd

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SPH3127, covering 2021-11-15 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis [Phase 2]